Leveraging cutting-edge epilepsy research to save lives
Leveraging cutting-edge epilepsy research to save lives
"The Cain Labs were founded to alleviate the terrible suffering of childhood epilepsies. Over the past 30 years, we've made significant progress, and today we are expanding our vision to aspire to treat neuropsychiatric and cognitive comorbidities, as well." — Dr. Sameer Sheth, Director
Latest news and discoveries
Novel gene therapy improves outcomes for animal models with STXBP1 disorder
Translating our discovery pipeline into effective new treatments
By implementing cutting-edge neuromodulatory techniques that target underlying brain circuits, Cain Labs investigators are translating basic scientific research into new treatments for epilepsy and other related brain diseases — including neuropsychiatric and mood disorders.
Help fund a better future
Your generous donations make our research possible. Give today, and you’ll help us continue our search for answers and give children with devastating neurological conditions the promise of a brighter tomorrow.
